Magnesium and cancer: A dangerous liason

Magnesium Research

Volumn 24, Issue 3, 2011, Pages

  Castiglioni, Sara ^a   Maier, Jeanette A M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer; Cetuximab; Cisplatin; Magnesium; Metastasis

Indexed keywords

MAGNESIUM;

ANIMAL; ARTICLE; CELL CULTURE; CELL TRANSFORMATION; DISEASE MODEL; HUMAN; MAGNESIUM DEFICIENCY; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; NEOPLASMS;

ANIMALIA; MUS;

EID: 80054941051     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2011.0285     Document Type: Article

References (58)

1. Jemal A, Bray F, Center M M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 6: 169-90.
2. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the US today. J Natl Cancer Inst 1981; 66: 1191-308.
3. Wolf FI, Trapani V. Cell (patho)physiology of magnesium. Clin Sci 2008; 114: 27-35.
4. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr 2003; 133: 2879-82.
5. Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, Cohen JI, Uzel G, Su HC, Lenardo MJ. Second messenger role for magnesium2+ revealed by human T-cell immunodeficiency. Nature 2011; 475: 471-6.
6. Wolf FI, Cittadini AR, Maier JA. Magnesium and tumors: ally or foe? Cancer Treatment Rev 2009; 35: 378-82.
7. Wolf FI, Maier JA, Nasulewicz A, Feillet-Coudray C, Mazur A, Simonacci M, Cittadini A. Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys 2007; 458: 24-32.
8. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 2009; 297: C493-502.
9. Günther T. Comment on the number of magnesium activated enzymes. Magnes Res 2008; 21: 185-7.
10. Koppenol WH, Bounds PL, Dang CV. OttoWarburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-37.
11. Adhikari S, Toretsky JA, Yuan L, Roy R. Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine- DNA glycosylase. J Biol Chem 2006; 281: 29525-32.
12. Bernards R. Wip-ing out cancer. Nat genet 2004; 36: 319-20.
13. Le Guezennec X, Bulavin DV. WIP1 phosphatase at the crossroads of cancer and aging. Trends in Biochemical Sciences 2010; 35: 109-14.
14. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
15. Hanahan D, Weinberg RA. The hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
16. Lue NF. Sequence-specific and conformationdependent binding of yeast telomerase RNA to single-stranded telomeric DNA. Nucleic Acids Res 1999; 27: 2560-7.
17. Yuan BF, Xue Y, Luo M, Hao YH, Tan Z. Two DNAzymes targeting the telomerase mRNA with large difference in magnesium2+ concentration for maximal catalytic activity. Int J Biochem Cell Biol 2007; 39: 1119-29.
18. Zhang ML, Tong XJ, Fu XH, Zhou BO, Wang J, Liao XH, Li QJ, Shen N, Ding J, Zhou JQ. Yeast telomerase subunit Est1p has guanine quadruplex-promoting activity that is required for telomere elongation. Nat Struct Mol Biol 2010; 17: 202-9.
19. Ferrè S, Baldoli E, Leidi M, Maier JA. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim Biophys Acta 2010; 1802: 952-8.
20. Killilea DW, Maier JA. A connection between magnesium deficiency and aging: new insights from cellular studies. Magnes Res 2008; 21: 77-82.
21. Campisi J. Cancer and aging: rival demons? Nat Rev Cancer 2003; 3: 339-49.
22. Bernardini D, Nasulewicz A, Mazur A, Maier JA. Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Frontiers Biosci 2005; 10: 1177-82.
23. Maier JA, Nasulewicz-Goldeman A, Simonacci M, Boninsegna A, Mazur A, Wolf FI. Insights into the mechanisms involved in magnesium-dependent inhibition of primary tumor growth. Nutr Cancer 2007; 59: 192-8.
24. Poirier LA, Theiss JC, Arnold LJ, Shimkin MB. Inhibition by magnesium and calcium acetates of lead subacetate- and nickel acetate-induced lung tumors in strain A mice. Cancer Res 1984; 44: 1520-2.
25. Kasprzak KS, Diwan BA, Rice JM. Iron accelerates while magnesium inhibits nickel-induced carcinogenesis in the rat kidney. Toxicology 1994; 90: 129-40.
26. Patiroǧlu T, Sahin G, Kontaş O, Uzüm K, Saraymen R. Protective effect of magnesium supplementation on experimental 3-methyl cholanthrene-induced fibrosarcoma and changes in tissue magnesium distribution during carcinogenesis in rats. Biol Trace Elem Res 1997; 56: 179-85.
27. Mori H, Tanaka T, Sugie S, Yoshimi N, Kawamori T, Hirose Y, Ohnishi M. Chemopreventium by naturally occuring and sinthetic agents in oral, liver and large bowel carcinogenesis. J Cell Biochem Suppl 1997; 27: 35-41.
28. Mills BJ, Lindeman RD, Lang CA. Magnesium deficiency inhibits biosynthesis of blood glutathione and tumor growth in the rat. Proc Soc Exp Biol Med 1986; 181: 326-32.
29. Nasulewicz A, Wietrzyk J, Wolf FI, Dzimira S, Madej J, Maier JA, Rayssiguier Y, Mazur A, Opolski A. Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice. Biochim Biophys Acta-Molecular Basis Of Disease 2004; 1739: 26-32.
30. Torii S, Kobayashi K, Takahashi M, Katahira K, Goryo K, Matsushita N, Yasumoto K, Fujii- Kuriyama Y, Sogawa K. Magnesium deficiency causes loss of response to intermittent hypoxia in paraganglion cells. J Biol Chem 2009; 284: 19077-89.
31. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56.
32. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: link to genetic instability. Carcinogenesis 2009; 30: 1073-81.
33. Royuela M, Rodríguez-Berriguete G, Fraile B, Paniagua R. TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate. Histol Histopathol 2008; 23: 1279-90.
34. Ma W, Chen J, Xue X, Wang Z, Liu H, Wang T, Bai Y, Tang SC, Zhou Q. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing. Biochem Biophys Res Commun 2008; 371: 425-30.
35. Boissan M, Wendum D, Arnaud-Dabernat S, Munier A, Debray M, Lascu I, Daniel JY, Lacombe ML. Increased lung metastasis in transgenic NM23- Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst 2005; 97: 836-45.
36. Yang CY, Chiu HF, Tsai SS, Wu TN, Chang CC. Calcium and magnesium in drinking water and the risk of death from esophageal cancer. Magnes Res 2002; 15: 215-22.
37. Tukiendorf A, Rybak Z. New data on ecological analysis of possible relationship between magnesium in drinking water and liver cancer. Magnes Res 2004; 17: 46-52.
38. Yang CY, Chiu HF, Tsai SS, Cheng MF, Lin MC, Sung FC. Calcium and magnesium in drinkingwater and the risk of death from prostate cancer. J Toxicol Environ Health A 2000; 60: 17-26.
39. Chiu HF, Chang CC, Yang CY. Calcium and magnesium in drinking water and the risk of death from ovarian cancer. Magnes Res 2004; 17: 28-34.
40. Larsson SC, Bergkvist L, Wolk A. Magnesium intake in relation to risk of colon cancer in women. JAMA2005; 293: 86-9.
41. Folsom AR, Hong CP. Magnesium intake and reduced risk of colon cancer in a prospective study of women. Am J Epidemiol 2006; 163: 232-5.
42. van den Brandt PA, Smits KM, Goldbohm RA, Weijenberg MP. Magnesium intake and colon cancer risk in the Netherlans Cohort Study. Br J Cancer 2007; 96: 510-3.
43. Chiu HF, Tsai SS, Wu TN, Yang CY. Colon cancer and the content of nitrate and magnesium in drinking water. Mag Res 2010; 23: 81-9.
44. Ma E, Sasazuki S, Inoue M, Iwasaki M, Sawada N, Takachi R, Tsugane S. High dietary intake of magnesium may decrease risk of colorectal cancer in Japanese men. J Nutr 2010; 140: 779-85.
45. Dai Q, Shrubsole J, Ness RM, Schlundt D, Cai Q, Smalley WE, Li M, Shyr Y, Zheng W. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr 2007; 86: 743-51.
46. Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, Kurosaki T, Fleig A, Scharenberg AM. Regulation of vertebrate cellular magnesium homeostasis by TRPM7. Cell 2003; 114: 191-200.
47. Mahabir S, Wei Q, Barrera SL, Dong YQ, Etzel CJ, Spitz MR, Forman MR. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis 2008; 29: 949-56.
48. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006; 22: 471-6.
49. Mahabir S, Forman MR, Dong YQ, Park Y, Hollenbeck A, Schatzkin A. Mineral intake and lung cancer risk in the NIH-American Association of Retired Persons Diet and Health study. Cancer Epidemiol Biomarkers Prev 2010; 19: 1976-83.
50. Sartori S, Nielsen I, Tassinari D, Mazzotta D, Vecchiatti G, Sero A, Abbasciano V. Serum and erythrocyte magnesium concentrations in solid tumors: relationship with stage and malignancy. Magnes Res 1992; 5: 189-92.
51. Cohen L, Kitzes R. Early radiation induced proctosigmoiditis responds to magnesium therapy. Magnesium 1985; 4: 16-9.
52. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007; 334: b115-24.
53. Muallem S, Moe OW. When EGF is offside, magnesium is wasted. J Clin Invest 2007; 117: 2086-9.
54. Vincenzi B, Santini D, Galluzzo S, Russo A, Fulfaro F, Silletta M F, Battistoni F, Rocci L, Zobel BB, Adamo V, Dicuonzo G, Tonini G. Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Clin Cancer Res 2008; 14: 4219-24.
55. Vincenzi B, Galluzzo S, Santini D, Rocci L, Loupakis F, Correale P, Addeo R, Zoccoli A, Napolitano A, Graziano F, Ruzzo A, Falcone A, Francini G, Dicuonzo G, Tonini G. Early magnesium modi-fications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients. Ann Oncol 2011; 22: 1141-6.
56. Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 2010; 68: 333-40.
57. Rosanoff A. Rising Ca:magnesium intake ratio from food in USA adults: a concern? Magnes Res 2010; 23: S181-93.
58. Sahmoun AE, Singh BB. Does a higher ratio of serum calcium to magnesium increase the risk for postmenopausal breast cancer? Med Hypotheses 2010; 75: 315-8.